Charles River Laboratories to acquire CROs Argenta and BioFocus.

FDA approves Eliquis (apixaban) for DVT and PE in patients who have undergone hip or knee replacement surgery.

New injection-delivery systems with multiple closure points pose challenges for container closure integrity testing.

Catalent will recognize 80 years of softgel advancements with presentations at INTERPHEX.

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

FDA clarifies recommendations for injectable drug products packaged in vials and ampules.

Almac expands technical, project, and operational resources in Asia.

To gain insights into the current trends of the biotechnology sector in the United Kingdom, Pharmaceutical Technology Europe spoke with Steve Bates, chief executive officer of the BioIndustry Association (BIA), the trade association for biotech companies in the UK.

$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.

CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.

Impact Analytical's facility in Michigan adds staff and instrumentation.

Beckman Coulter partners with Wyatt Technology to develop and market products for nanoparticle characterization.

Pfizer initiates nationwide voluntary recall of two lots Effexor XR and one lot Greenstone's Venlafaxine HCI.

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

Agencies extend successful pilot program to further harmonization of QbD topics.

FDA approves the extended-release Bydureon Pen for the treatment of type 2 diabetes.

Novartis calls for more research to understand and find treatments for rare disease.

Waters celebrates ten-year anniversary of the ACQUITY UPLC System.

New guidance from FDA asks for documentation of CMC postapproval manufacturing changes.

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.

Conference sessions from PDA and PharmTech expand educational opportunities at INTERPHEX 2014.

The root cause of drug shortages is mismanagement of variation.

USP evaluates quality attributes for synthetic peptides.

Lilly Diabetes supports the American Diabetes Association for the seventh year in a row.

MedImmune and AstraZeneca enter a three-year collaboration with the Clinical and Translational Science Institute at the UC San Francisco.

Discovery of split and broken tablets led to drug recalls.

Experts note hepatitis C screening is important for getting care early.

AbbVie launches art initiative designed to explore impact of chronic inflammatory diseases.